Q1 EPS Estimates for Core Scientific Lowered by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZ) – Investment analysts at Roth Capital dropped their Q1 2025 earnings estimates for shares of Core Scientific in a report released on Wednesday, April 9th. Roth Capital analyst D. Aftahi now anticipates that the company will earn ($0.14) per share for the quarter, down from their prior forecast of ($0.11). The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific’s Q2 2025 earnings at ($0.12) EPS, Q3 2025 earnings at ($0.12) EPS, Q4 2025 earnings at ($0.05) EPS, FY2025 earnings at ($0.43) EPS and Q1 2026 earnings at ($0.02) EPS.

Core Scientific (NASDAQ:CORZ) last posted its earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.09. The business had revenue of $94.93 million during the quarter, compared to the consensus estimate of $97.07 million.

CORZ has been the topic of several other reports. Canaccord Genuity Group reaffirmed a “buy” rating and set a $17.00 price objective on shares of Core Scientific in a research report on Wednesday, March 12th. HC Wainwright restated a “buy” rating and set a $17.00 price target on shares of Core Scientific in a research report on Tuesday, March 11th. Cantor Fitzgerald reduced their price target on Core Scientific from $24.00 to $21.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Keefe, Bruyette & Woods began coverage on Core Scientific in a research report on Monday, January 27th. They set an “outperform” rating and a $22.00 price objective for the company. Finally, Craig Hallum started coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They issued a “buy” rating and a $24.00 target price on the stock. Fifteen equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $19.07.

Core Scientific Trading Down 3.0 %

NASDAQ:CORZ opened at $6.85 on Monday. Core Scientific has a 12 month low of $2.61 and a 12 month high of $18.63. The company has a 50-day moving average price of $9.16 and a 200-day moving average price of $12.65. The stock has a market cap of $2.02 billion, a price-to-earnings ratio of -1.27 and a beta of 6.80.

Insider Buying and Selling

In related news, CEO Adam Taylor Sullivan sold 369,712 shares of Core Scientific stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $16.24, for a total value of $6,004,122.88. Following the completion of the sale, the chief executive officer now directly owns 3,758,793 shares in the company, valued at approximately $61,042,798.32. This trade represents a 8.96 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Todd M. Duchene sold 25,277 shares of the company’s stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $16.24, for a total transaction of $410,498.48. Following the transaction, the insider now owns 2,023,423 shares in the company, valued at $32,860,389.52. This represents a 1.23 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 530,041 shares of company stock worth $7,870,352 in the last three months. Insiders own 32.00% of the company’s stock.

Institutional Investors Weigh In On Core Scientific

Hedge funds have recently added to or reduced their stakes in the stock. Wellington Shields & Co. LLC purchased a new position in shares of Core Scientific in the 4th quarter worth $26,000. First Horizon Advisors Inc. purchased a new position in Core Scientific in the fourth quarter worth about $34,000. Newbridge Financial Services Group Inc. bought a new stake in shares of Core Scientific during the 4th quarter valued at about $42,000. GAMMA Investing LLC increased its position in shares of Core Scientific by 1,722.3% during the 1st quarter. GAMMA Investing LLC now owns 8,565 shares of the company’s stock valued at $62,000 after purchasing an additional 8,095 shares during the last quarter. Finally, Vestcor Inc bought a new position in shares of Core Scientific in the 4th quarter worth approximately $66,000.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.